PROGRAM AT A GLANCE
2:15 PM - 2:30 PMJoint ILCA-AASLD-CASL SymposiumStrategies for HCC prevention, including in non-viral liver disease 
2:30 PM - 2:45 PMJoint ILCA-AASLD-CASL SymposiumEmerging approaches to HCC surveillance 
2:45 PM - 3:00 PMJoint ILCA-AASLD-CASL SymposiumPrecision surveillance: close to reality? 
3:00 PM - 3:15 PMJoint ILCA-AASLD-CASL SymposiumRecall systems and linkage to care: Important steps after surveillance 
3:15 PM - 3:30 PMJoint ILCA-AASLD-CASL SymposiumSystem- and population-level approaches to prevention and surveillance 
3:30 PM - 3:45 PMOpening Remarks from CASL President Carla Coffin
3:45 PM - 4:00 PMOpening Remarks from Canadian Liver Foundation Jennifer Nebesky
4:00 PM - 4:30 PMKeynote Speaker LectureState of the Art: Towards an AI-Driven Precision Medicine approach in Hepatocellular Carcinoma 
4:30 PM - 6:30 PMWelcome Reception + Networking  
9:00 AM - 9:15 AMEpidemiology/Diagnosis/StagingEpidemiology: The burden of HCC in CanadaHélène Castel
9:20 AM - 9:50 AMEpidemiology/Diagnosis/StagingDiagnostic: The best modality to diagnose HCCStephanie Wilson
9:50 AM - 10:05 AMEpidemiology/Diagnosis/StagingStaging: Utility of the BCLC staging systemRobert Grant
10:05 AM - 10:20 AMEpidemiology/Diagnosis/StagingAdvances in Multidisciplinary Tumor Board Rounds (MTBR)Mayur Brahmania
10:20 AM - 10:30 AMEpidemiology/Diagnosis/StagingQ&A 
10:30 AM - 11:00 AMCoffee Break  
11:00 AM - 11:15 AMEarly & Intermediate HCCSurgery as first line therapyChaya Schwartz
11:15 AM - 11:30 AMEarly & Intermediate HCCHow/When/Why liver transplant for HCCGonzalo Sapisochin
11:30 AM - 11:45 AMEarly & Intermediate HCCThe role of SBRT in HCC managementMichael Lock
11:45 AM - 12:00 PMEarly & Intermediate HCCThe role of LRT in HCC cureDavid Liu
12:00 PM - 12:15 PMEarly & Intermediate HCCQ&A 
12:15 PM - 1:15 PMLunch Break  
1:15 PM - 1:30 PMLate HCC & Palliative CarePrognostic Value of HCC Pathology 
1:30 PM - 1:45 PMLate HCC & Palliative CareHow to use IO therapyAnna Saborowski
1:45 PM - 2:00 PMLate HCC & Palliative CareUse of biomarker in predicting response to treatmentArndt Vogel
2:00 PM - 2:15 PMLate HCC & Palliative CareUtility of Palliative Care in HCC care. When is too early? 
2:15 PM - 2:30 PMLate HCC & Palliative CareQ&A 
2:30 PM - 3:00 PMAfternoon Break  
3:00 PM - 3:15 PMFuture DirectionsThe Importance and Impactof Cancer Research in CanadaJim Woodgett
3:15 PM - 3:30 PMFuture DirectionsHow to incorporate the patient voice in HCC care 
3:30 PM - 3:45 PMFuture DirectionsThe future of AI in HCCMamatha Bhat
4:00 PM - 4:15 PMFuture DirectionsQ&A 
4:15 PM - 4:30 PMClosing Remarks Mamatha Bhat
Mayur Brahmania